India Capital Growth (IGC) Competitors GBX 176 -0.25 (-0.14%) As of 11:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock IGC vs. SLN, AMYT, OGN, BMY, GPH, AURA, ARTL, PHAR, KOD, and ORPHShould you be buying India Capital Growth stock or one of its competitors? The main competitors of India Capital Growth include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Origin Enterprises (OGN), Bloomsbury Publishing (BMY), Global Ports (GPH), Aura Energy (AURA), Alpha Real Trust (ARTL), Pharos Energy (PHAR), Kodal Minerals (KOD), and Open Orphan (ORPH). These companies are all part of the "pharmaceutical products" industry. India Capital Growth vs. Its Competitors Silence Therapeutics Amryt Pharma Origin Enterprises Bloomsbury Publishing Global Ports Aura Energy Alpha Real Trust Pharos Energy Kodal Minerals Open Orphan India Capital Growth (LON:IGC) and Silence Therapeutics (LON:SLN) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk. Is IGC or SLN more profitable? India Capital Growth has a net margin of 93.35% compared to Silence Therapeutics' net margin of 0.00%. India Capital Growth's return on equity of 25.12% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets India Capital Growth93.35% 25.12% 15.98% Silence Therapeutics N/A N/A N/A Does the media favor IGC or SLN? In the previous week, India Capital Growth's average media sentiment score of 0.00 equaled Silence Therapeutics'average media sentiment score. Company Overall Sentiment India Capital Growth Neutral Silence Therapeutics Neutral Which has higher valuation and earnings, IGC or SLN? India Capital Growth has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than India Capital Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIndia Capital Growth£46.21M3.29£43.14M£49.523.55Silence Therapeutics£11.35M0.00N/A-£48.60N/A Do institutionals & insiders hold more shares of IGC or SLN? 24.3% of India Capital Growth shares are owned by institutional investors. 0.2% of India Capital Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryIndia Capital Growth beats Silence Therapeutics on 8 of the 8 factors compared between the two stocks. Get India Capital Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGC vs. The Competition Export to ExcelMetricIndia Capital GrowthAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£151.96M£1.29B£6.31B£3.07BDividend YieldN/A4.41%4.19%5.02%P/E Ratio3.5522.4014.17167.05Price / Sales3.292,589.201,857.94328,748.07Price / Cash97.3160.70127.2327.97Price / Book0.891.442.244.49Net Income£43.14M£265.04M£1.23B£5.90B7 Day Performance-1.68%0.21%0.56%0.95%1 Month Performance-1.40%0.92%2.49%4.41%1 Year Performance-2.96%8.64%23.86%56.53% India Capital Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGCIndia Capital GrowthN/AGBX 176-0.1%N/A-2.3%£151.96M£46.21M3.5561SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownOGNOrigin EnterprisesN/AGBX 3.78+1.8%N/A+25.8%£398.59M£183.08B10.9210,000Dividend IncreaseBMYBloomsbury Publishing3.812 of 5 starsGBX 485.50-0.4%GBX 825+69.9%-29.2%£391.77M£382.40M10.3934,300Positive NewsInsider TradeGPHGlobal PortsN/AN/AN/AN/A£231.21M£193.58M30,000.0020AURAAura EnergyN/AGBX 7.30+0.7%N/A+0.7%£131.21MN/A-16,001.7550Gap UpARTLAlpha Real TrustN/AN/AN/AN/A£113.12M£8.46M96.445Gap UpHigh Trading VolumePHARPharos EnergyN/AGBX 21flatN/A-16.0%£104.76M£196.07M-2.23280Positive NewsKODKodal Minerals1.7878 of 5 starsGBX 0.35+3.5%GBX 1.23+248.0%-29.6%£70.99MN/A2,705.6190News CoverageGap DownORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179 Related Companies and Tools Related Companies Silence Therapeutics Competitors Amryt Pharma Competitors Origin Enterprises Competitors Bloomsbury Publishing Competitors Global Ports Competitors Aura Energy Competitors Alpha Real Trust Competitors Pharos Energy Competitors Kodal Minerals Competitors Open Orphan Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IGC) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding India Capital Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share India Capital Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IGC Stock Alerts